Cope Anwen L, Francis Nick, Wood Fiona, Chestnutt Ivor G
Cardiff and Vale University Health Board, Heath Park, Cardiff, UK, CF14 4YS.
Cochrane Database Syst Rev. 2018 Sep 27;9(9):CD010136. doi: 10.1002/14651858.CD010136.pub3.
BACKGROUND: Dental pain can have a detrimental effect on quality of life. Symptomatic apical periodontitis and acute apical abscess are common causes of dental pain and arise from an inflamed or necrotic dental pulp, or infection of the pulpless root canal system. Clinical guidelines recommend that the first-line treatment for teeth with these conditions should be removal of the source of inflammation or infection by local, operative measures, and that systemic antibiotics are currently only recommended for situations where there is evidence of spreading infection (cellulitis, lymph node involvement, diffuse swelling) or systemic involvement (fever, malaise). Despite this, there is evidence that dentists frequently prescribe antibiotics in the absence of these signs. There is concern that this could contribute to the development of antibiotic-resistant bacterial colonies within both the individual and the community. This review is an update of the original version that was published in 2014. OBJECTIVES: To evaluate the effects of systemic antibiotics provided with or without surgical intervention (such as extraction, incision and drainage of a swelling, or endodontic treatment), with or without analgesics, for symptomatic apical periodontitis and acute apical abscess in adults. SEARCH METHODS: Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 26 February 2018), the Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 1) in the Cochrane Library (searched 26 February 2018), MEDLINE Ovid (1946 to 26 February 2018), Embase Ovid (1980 to 26 February 2018), and CINAHL EBSCO (1937 to 26 February 2018). The US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov) and the World Health Organization International Clinical Trials Registry Platform were searched for ongoing trials. A grey literature search was conducted using OpenGrey (to 26 February 2018) and ZETOC Conference Proceedings (1993 to 26 February 2018). No restrictions were placed on the language or date of publication when searching the electronic databases. SELECTION CRITERIA: Randomised controlled trials of systemic antibiotics in adults with a clinical diagnosis of symptomatic apical periodontitis or acute apical abscess, with or without surgical intervention (considered in this situation to be extraction, incision and drainage or endodontic treatment) and with or without analgesics. DATA COLLECTION AND ANALYSIS: Two authors screened the results of the searches against inclusion criteria, extracted data and assessed risk of bias independently and in duplicate. We calculated mean differences (MD) (standardised mean difference (SMD) when different scales were reported) and 95% confidence intervals (CI) for continuous data. A fixed-effect model was used in the meta-analysis as there were fewer than four studies. We contacted study authors to obtain missing information. MAIN RESULTS: We included two trials in this review, with 62 participants included in the analyses. Both trials were conducted in university dental schools in the USA and compared the effects of oral penicillin V potassium (penicillin VK) versus a matched placebo when provided in conjunction with a surgical intervention (total or partial pulpectomy) and analgesics to adults with acute apical abscess or symptomatic necrotic tooth. The patients included in these trials had no signs of spreading infection or systemic involvement (fever, malaise). We assessed one study as having a high risk of bias and the other study as having unclear risk of bias.The primary outcome variables reported in both studies were participant-reported pain and swelling (one trial also reported participant-reported percussion pain). One study reported the type and number of analgesics taken by participants. One study recorded the incidence of postoperative endodontic flare-ups (people who returned with symptoms that necessitated further treatment). Adverse effects, as reported in one study, were diarrhoea (one participant, placebo group) and fatigue and reduced energy postoperatively (one participant, antibiotic group). Neither study reported quality of life measurements.Objective 1: systemic antibiotics versus placebo with surgical intervention and analgesics for symptomatic apical periodontitis or acute apical abscessTwo studies provided data for the comparison between systemic antibiotics (penicillin VK) and a matched placebo for adults with acute apical abscess or a symptomatic necrotic tooth when provided in conjunction with a surgical intervention. Participants in one study all underwent a total pulpectomy of the affected tooth, while participants in the other study had their tooth treated by either partial or total pulpectomy. Participants in both trials received oral analgesics. There were no statistically significant differences in participant-reported measures of pain or swelling at any of the time points assessed within the review. The MD for pain (short ordinal numerical scale 0 to 3) was -0.03 (95% CI -0.53 to 0.47) at 24 hours; 0.32 (95% CI -0.22 to 0.86) at 48 hours; and 0.08 (95% CI -0.38 to 0.54) at 72 hours. The SMD for swelling was 0.27 (95% CI -0.23 to 0.78) at 24 hours; 0.04 (95% CI -0.47 to 0.55) at 48 hours; and 0.02 (95% CI -0.49 to 0.52) at 72 hours. The body of evidence was assessed as at very low quality.Objective 2: systemic antibiotics without surgical intervention for adults with symptomatic apical periodontitis or acute apical abscessWe found no studies that compared the effects of systemic antibiotics with a matched placebo delivered without a surgical intervention for symptomatic apical periodontitis or acute apical abscess in adults. AUTHORS' CONCLUSIONS: There is very low-quality evidence that is insufficient to determine the effects of systemic antibiotics on adults with symptomatic apical periodontitis or acute apical abscess.
背景:牙痛会对生活质量产生不利影响。症状性根尖周炎和急性根尖脓肿是牙痛的常见原因,由牙髓发炎或坏死,或无牙髓根管系统感染引起。临床指南建议,对于患有这些病症的牙齿,一线治疗应通过局部手术措施消除炎症或感染源,目前仅在有感染扩散证据(蜂窝织炎、淋巴结受累、弥漫性肿胀)或全身受累(发热、不适)的情况下推荐使用全身抗生素。尽管如此,有证据表明牙医在没有这些体征的情况下经常开抗生素。人们担心这可能会导致个体和社区内产生耐药性细菌菌落。本综述是2014年发表的原始版本的更新。 目的:评估全身使用抗生素,无论是否联合手术干预(如拔牙、切开引流肿胀或根管治疗),无论是否联合使用镇痛药,对成人症状性根尖周炎和急性根尖脓肿的影响。 检索方法:Cochrane口腔健康信息专家检索了以下数据库:Cochrane口腔健康试验注册库(截至2018年2月26日)、Cochrane图书馆中的Cochrane对照试验中央注册库(CENTRAL;2018年第1期,检索于2018年2月26日)、MEDLINE Ovid(1946年至2018年2月26日)、Embase Ovid(1980年至2018年2月26日)以及CINAHL EBSCO(1937年至2018年2月26日)。检索了美国国立卫生研究院正在进行的试验注册库(ClinicalTrials.gov)和世界卫生组织国际临床试验注册平台以查找正在进行的试验。使用OpenGrey(截至2018年2月26日)和ZETOC会议论文集(1993年至2018年2月26日)进行灰色文献检索。检索电子数据库时对语言或出版日期没有限制。 入选标准:对临床诊断为症状性根尖周炎或急性根尖脓肿的成人使用全身抗生素的随机对照试验,无论是否联合手术干预(在这种情况下认为是拔牙、切开引流或根管治疗),无论是否联合使用镇痛药。 数据收集与分析:两位作者根据纳入标准筛选检索结果,独立且重复地提取数据并评估偏倚风险。对于连续数据,我们计算了平均差(MD)(当报告不同量表时为标准化平均差(SMD))和95%置信区间(CI)。由于研究少于四项,在荟萃分析中使用了固定效应模型。我们联系研究作者以获取缺失信息。 主要结果:本综述纳入了两项试验,62名参与者纳入分析。两项试验均在美国的大学牙科学院进行,比较了口服青霉素V钾(青霉素VK)与匹配安慰剂在联合手术干预(全部或部分牙髓摘除术)和镇痛药时对患有急性根尖脓肿或症状性坏死牙的成人的效果。这些试验中的患者没有感染扩散或全身受累(发热、不适)的体征。我们将一项研究评估为具有高偏倚风险,另一项研究评估为具有不明确的偏倚风险。两项研究报告的主要结局变量均为参与者报告的疼痛和肿胀(一项试验还报告了参与者报告的叩击痛)。一项研究报告了参与者服用的镇痛药类型和数量。一项研究记录了术后根管治疗急性发作的发生率(因症状复发需要进一步治疗的人)。一项研究报告的不良反应为腹泻(一名参与者,安慰剂组)以及术后疲劳和精力下降(一名参与者,抗生素组)。两项研究均未报告生活质量测量结果。 目标1:全身使用抗生素与安慰剂联合手术干预和镇痛药治疗症状性根尖周炎或急性根尖脓肿 两项研究提供了数据,用于比较全身使用抗生素(青霉素VK)与匹配安慰剂对患有急性根尖脓肿或症状性坏死牙的成人在联合手术干预时的效果。一项研究中的参与者均接受了患牙的全部牙髓摘除术,而另一项研究中的参与者的牙齿接受了部分或全部牙髓摘除术。两项试验的参与者均接受口服镇痛药。在本综述评估的任何时间点,参与者报告的疼痛或肿胀测量结果均无统计学显著差异。24小时时疼痛的MD(短序数量表0至3)为-0.03(95%CI -0.53至0.47);48小时时为0.32(95%CI -0.22至0.86);72小时时为0.08(95%CI -0.38至0.54)。肿胀的SMD在24小时时为0.27(95%CI -0.23至0.78);48小时时为0.04(95%CI -0.47至0.55);72小时时为0.02(95%CI -0.49至0.52)。证据质量被评估为极低。 目标2:全身使用抗生素不联合手术干预治疗成人症状性根尖周炎或急性根尖脓肿 我们未发现有研究比较全身使用抗生素与匹配安慰剂在不联合手术干预时对成人症状性根尖周炎或急性根尖脓肿的效果。 作者结论:证据质量极低,不足以确定全身使用抗生素对患有症状性根尖周炎或急性根尖脓肿的成人的效果。
Cochrane Database Syst Rev. 2018-9-27
Cochrane Database Syst Rev. 2014-6-26
Cochrane Database Syst Rev. 2024-5-7
Cochrane Database Syst Rev. 2018-5-31
Cochrane Database Syst Rev. 2018-1-1
Cochrane Database Syst Rev. 2018-7-31
Cochrane Database Syst Rev. 2018-4-4
Cochrane Database Syst Rev. 2025-6-9
Cochrane Database Syst Rev. 2022-6-9
Cochrane Database Syst Rev. 2021-2-4
Drug Deliv. 2025-12
Front Microbiol. 2025-3-26
Cochrane Database Syst Rev. 2024-5-7
J Craniomaxillofac Surg. 2017-8-19
Evid Based Dent. 2016-6
Community Dent Oral Epidemiol. 2016-4
Cochrane Database Syst Rev. 2014-6-26
Int J Dent. 2009
Vojnosanit Pregl. 2009-7